STEREOTACTIC BODY RADIATION THERAPY AND ABIRATERONE ACETATE FOR PATIENTS AFFECTED BY OLIGOMETASTATIC CASTRATERESISTANT PROSTATE CANCER: A RANDOMIZED PHASE II TRIAL (ARTO-NCT03449719)

被引：0

作者：

Francolini, Giulio ^{[1
]}

Allegra, Andrea Gaetano ^{[2
]}

Caini, Saverio ^{[3
]}

Di Cataldo, Vanessa ^{[1
]}

Detti, Beatrice ^{[1
]}

Alitto, Anna Rita ^{[4
]}

Parisi, Silvana ^{[5
]}

D'angelillo, Rolando Maria ^{[6
]}

Bruni, Alessio ^{[7
]}

Ingrosso, Gianluca ^{[8
]}

Augugliaro, Matteo ^{[9
]}

Lorenzetti, Victoria ^{[2
]}

Orsatti, Carolina ^{[2
]}

Caprara, Luisa ^{[2
]}

Frosini, Giulio ^{[2
]}

Burchini, Luca ^{[2
]}

Lapini, Alberto ^{[10
]}

Triggiani, Luca ^{[11
]}

Desideri, Isacco ^{[2
]}

Meattini, Icro ^{[2
]}

Livi, Lorenzo ^{[2
]}

机构：

[1] Azienda Osped Univ Careggi, Dept Oncol, Radiat Oncol Unit, Florence, Italy

[2] Univ Florence, M Serio Dept Biomed Expt & Clin Sci, Florence, Italy

[3] Inst Canc Res Prevent & Clin Network ISPO, Canc Risk Factors & Lifestyle Epidemiol Unit, Florence, Italy

[4] A Gemelli Policlin Univ, UOC Radioterapia Oncol, Rome, Italy

[5] Univ Messina, Radiat Oncol Unit, Messina, Italy

[6] Univ Roma Tor Vergata, Dept Biomed & Prevent, Radiat Oncol, Rome, Italy

[7] Univ Hosp Modena, Dept Hematol & Oncol, Radiat Oncol Unit, Modena, Italy

[8] Univ Perugia, Radiat Oncol Sect, Dept Med & Surg, Perugia, Italy

[9] Azienda USL IRCCS Reggio Emilia, Unit Radiotherapy, Reggio Emilia, Italy

[10] Univ Florence, Dept Urol, Florence, Italy

[11] Univ Brescia, Dept Radiat Oncol, Brescia, Italy

来源：

ANTICANCER RESEARCH | 2023年 / 43卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：4764 / 4765

页数：2

共 50 条

[1] Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)
Francolini, Giulio
Allegra, Andrea Gaetano
Detti, Beatrice
Di Cataldo, Vanessa
Caini, Saverio
Bruni, Alessio
Ingrosso, Gianluca
D'Angelillo, Rolando Maria
Alitto, Anna Rita
Augugliaro, Matteo
Triggiani, Luca
Parisi, Silvana
Facchini, Gaetano
Banini, Marco
Simontacchi, Gabriele
Desideri, Isacco
Meattini, Icro
Valicenti, Richard K.
Livi, Lorenzo
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (36) : 5561 - +
[2] Early outcomes from a phase II randomized trial testing stereotactic body radiation therapy in patients undergoing I line treatment with abiraterone acetate for oligometastatic castration resistant prostate cancer (ARTO trial-NCT03449719)
Francolini, G.
Allegra, A. G.
Caini, S.
Detti, B.
Di Cataldo, V.
Alitto, A.
Parisi, S.
D'Angelillo, R. M.
Bruni, A.
Ingrosso, G.
Timon, G.
Burchini, L.
Frosini, G.
Valzano, M.
Ganovelli, M.
Desideri, I.
Visani, L.
Olmetto, E.
Becherini, C.
Salvestrini, V.
Lapini, A.
Meattini, I.
Livi, L.
EUROPEAN UROLOGY, 2023, 83
[3] Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients
Francolini, G.
Detti, B.
Di Cataldo, V.
Caini, S.
Alitto, A. R.
Parisi, S.
Demofonti, C.
Bruni, A.
Ingrosso, G.
Timon, G.
Allegra, A. G.
Burchini, L.
Salvestrini, V.
Frosini, G.
Cerbai, C.
Visani, L.
Becherini, C.
Desideri, I.
Meattini, I.
Livi, L.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1167 - S1168
[4] ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate.
Francolini, Giulio
Detti, Beatrice
Di Cataldo, Vanessa
Caini, Saverio
Alitto, Anna Rita
Parisi, Silvana
Demofonti, Chiara
Bruni, Alessio
Ingrosso, Gianluca
Timon, Giorgia
Allegra, Andrea
Aquilano, Michele
Ciccone, Lucia Pia
Salvestrini, Viola
Frosini, Giulio
Cerbai, Cecilia
Desideri, Isacco
Meattini, Icro
Mangoni, Monica
Livi, Lorenzo
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[5] ARTO trial (NCT03449719), a randomized phase II trial enrolling oligometastatic castration-resistant prostate cancer patients treated with first-line abiraterone acetate with or without stereotactic body radiation therapy: Preliminary results comprehensive of biochemical outcomes and circulating tumor cells analysis.
Francolini, Giulio
Garlatti, Pietro
Loi, Mauro
Detti, Beatrice
Aquilano, Michele
Allegra, Andrea
Guerrieri, Barbara
Salvestrini, Viola
Pinzani, Pamela
Bellini, Chiara
Salvianti, Francesca
Stocchi, Giulia
Ciccone, Lucia Pia
Salvatore, Giulia
Sottili, Mariangela
Di Cataldo, Vanessa
Desideri, Isacco
Mangoni, Monica
Meattini, Icro
Livi, Lorenzo
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[6] Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
Francolini, Giulio
Detti, Beatrice
Di Cataldo, Vanessa
Garlatti, Pietro
Aquilano, Michele
Allegra, Andrea
Lucidi, Sara
Cerbai, Cecilia
Ciccone, Lucia Pia
Salvestrini, Viola
Stocchi, Giulia
Guerrieri, Barbara
Visani, Luca
Loi, Mauro
Desideri, Isacco
Mangoni, Monica
Meattini, Icro
Livi, Lorenzo
RADIOLOGIA MEDICA, 2022, 127 (08): : 912 - 918
[7] Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
Giulio Francolini
Beatrice Detti
Vanessa Di Cataldo
Pietro Garlatti
Michele Aquilano
Andrea Allegra
Sara Lucidi
Cecilia Cerbai
Lucia Pia Ciccone
Viola Salvestrini
Giulia Stocchi
Barbara Guerrieri
Luca Visani
Mauro Loi
Isacco Desideri
Monica Mangoni
Icro Meattini
Lorenzo Livi
La radiologia medica, 2022, 127 : 912 - 918
[8] ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer.
Francolini, Giulio
Di Cataldo, Vanessa
Garlatti, Pietro
Detti, Beatrice
Caini, Saverio
Bruni, Alessio
Ingrosso, Gianluca
D'Angelillo, Rolando Maria
Alitto, Anna Rita
Augugliaro, Matteo
Triggiani, Luca
Parisi, Silvana
Facchini, Gaetano
Banini, Marco
Simontacchi, Gabriele
Desideri, Isacco
Meattini, Icro
Valicenti, Richard K.
Livi, Lorenzo
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 132 - 132
[9] Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
Francolini, Giulio
Bertini, Niccolo
Di Cataldo, Vanessa
Garlatti, Pietro
Aquilano, Michele
Caini, Saverio
Bruni, Alessio
Ingrosso, Gianluca
D'angelillo, Rolando Maria
Tagliaferri, Luca
Augugliaro, Matteo
Triggiani, Luca
Parisi, Silvana
Timon, Giorgia
Arcidiacono, Fabio
Marvaso, Giulia
Jereczek-Fossa, Barbara Alicja
Lancia, Andrea
Franzese, Ciro
Alongi, Filippo
Simontacchi, Gabriele
Greto, Daniela
Bonomo, Pierluigi
Loi, Mauro
Frosini, Giulio
Burchini, Luca
Desideri, Isacco
Meattini, Icro
Valicenti, Richard K.
Livi, Lorenzo
PROSTATE CANCER AND PROSTATIC DISEASES, 2025,
[10] A phase II randomized trial of observation versus stereotactic ablative radiation for oligometastatic prostate cancer (ORIOLE).
Phillips, Ryan
Radwan, Noura
Ross, Ashley
Rowe, Steven P.
Gorin, Michael A.
Antonarakis, Emmanuel S.
Deville, Curtiland
Greco, Stephen C.
Denmeade, Samuel R.
Paller, Channing Judith
Song, Daniel Y.
Diehn, Maximilian
Wang, Hao
Carducci, Michael Anthony
Pienta, Kenneth J.
Pomper, Martin G.
DeWeese, Theodore L.
Dicker, Adam P.
Eisenberger, Mario A.
Tran, Phuoc T.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

← 1 2 3 4 5 →